Options positioning on C has swung to its most defensive level in a year. The put-call ratio hit 1.43 on August 31 — a 52-week high — with a z-score of 2.46 standard deviations above the 20-day mean. That's the clearest signal in this week's data, and it's landing alongside a sharp short interest build and a softening analyst price target trend.
The PCR sat at just 1.25 for most of July. It broke above 1.36 in the final week of August and closed the month at 1.43. The 20-day mean is 1.32. A z-score of 2.46 means this level is statistically rare — a broad-market hedging cluster or a targeted downside bet, neither of which reflects confidence. The stock fell 0.96% on August 31 and has lost 0.63% over the past month.
Short interest climbed 21% in one week. The driver was a single-day spike on August 24, when shares short jumped from roughly 24.7 million to 29.9 million. The level stayed elevated through August 31 at 29.8 million shares, or 1.66% of free float. That remains a low absolute reading for a large-cap bank. Borrow availability stands at the maximum tracked level — every share borrowed has roughly 100 shares still available to lend. No squeeze risk is embedded here.
Following Citigroup's July earnings — which saw the stock fall 4.1% on the day — several analysts lowered price targets. UBS cut from $150 to $142 on August 3. Evercore ISI moved from $143 to $135 in July. Truist lowered from $158 to $154. RBC Capital held its Outperform rating and $150 target unchanged. The consensus remains Buy, with a mean target of $134.43 against the current price of $131.62. Upside to target is modest — under 2%.
Cost to borrow rose 52% over the past week to 0.41%. In absolute terms that remains near historic lows for Citi. It signals incrementally higher demand for borrows, consistent with the short interest build, but not a material constraint on short sellers.
See the live data behind this article on ORTEX.
Open C on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
